Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Helius Medical Technologies Inc (HSM.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 100,361
  • Shares Outstanding, K 25,866
  • Annual Sales, $ 478 K
  • Annual Income, $ -28,623 K
  • 60-Month Beta -1.83
  • Price/Sales 58.68
  • Price/Cash Flow N/A
  • Price/Book 6.27
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -1.24
  • Most Recent Earnings -0.06 on 03/31/19
  • Next Earnings Date 08/08/19
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Medical Devices

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.34
  • Number of Estimates 1
  • High Estimate -0.34
  • Low Estimate -0.34
  • Prior Year -1.01
  • Growth Rate Est. (year over year) +66.34%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.04 +22.70%
on 05/22/19
4.42 -15.61%
on 06/05/19
+0.68 (+22.30%)
since 05/17/19
3-Month
2.35 +58.72%
on 04/11/19
9.52 -60.82%
on 03/22/19
-5.76 (-60.70%)
since 03/15/19
52-Week
2.35 +58.72%
on 04/11/19
17.17 -78.28%
on 06/18/18
-13.46 (-78.30%)
since 06/15/18

Most Recent Stories

More News
Helius Medical Technologies, Inc. Announces Scientific Publication Confirming Tongue Stimulation with PoNS(TM) Alters Brain Activity

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today reported that a scientific paper entitled Human Translingual...

HSM.TO : 3.73 (-3.87%)
HSDT : 2.77 (-5.14%)
Helius Medical Technologies to Present at the JMP Securities Life Sciences Conference

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that management will participate in the JMP...

HSM.TO : 3.73 (-3.87%)
HSDT : 2.77 (-5.14%)
Helius Medical Technologies, Inc. Announces Addition of Three New PoNS(TM) Authorized Clinics in Canada

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today reported that three new clinics have been authorized to...

HSM.TO : 3.73 (-3.87%)
HSDT : 2.77 (-5.14%)
Helius Medical Technologies, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today reported financial results for the first quarter ended...

HSM.TO : 3.73 (-3.87%)
HSDT : 2.77 (-5.14%)
Global Cellulite Treatments Market Could Exceed $1.4 Billion by 2026

The global cellulite market and its largest segment, the non-invasive treatment sector, are both expected to grow at a healthy rate. A recent industry report on the entire cellulite market (from Transparency...

HSM.TO : 3.73 (-3.87%)
CTLT : 50.57 (+1.77%)
HSDT : 2.77 (-5.14%)
VRAY : 8.95 (+2.29%)
MDT : 97.32 (-0.18%)
SOLY : 16.64 (+16.36%)
Helius Medical Technologies, Inc. Provides Update on FDA's Review of its Request for De Novo Classification and 510(k) Clearance of the PoNS(TM) Device

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that the U.S. Food and Drug Administration (the...

HSM.TO : 3.73 (-3.87%)
HSDT : 2.77 (-5.14%)
Helius Medical Technologies to Release First Quarter of Fiscal Year 2019 Financial Results on May 9, 2019

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that first quarter of fiscal year 2019 financial...

HSM.TO : 3.73 (-3.87%)
HSDT : 2.77 (-5.14%)
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Introduces Full Year 2019 Outlook

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today reported financial results for the fourth...

HSM.TO : 3.73 (-3.87%)
HSDT : 2.77 (-5.14%)
Helius Medical Technologies, Inc. Announces First Patients in Canada Treated with Commercially Available PoNS(TM) Treatment

Helius Medical Technologies, Inc (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that it has begun treating patients in Canada...

HSM.TO : 3.73 (-3.87%)
HSDT : 2.77 (-5.14%)
Helius Medical Technologies, Inc. Announces Company-Hosted Event at Medical Meeting in March

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that it will be hosting an event at the following...

HSM.TO : 3.73 (-3.87%)
HSDT : 2.77 (-5.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Key Turning Points

2nd Resistance Point 3.90
1st Resistance Point 3.81
Last Price 3.73
1st Support Level 3.68
2nd Support Level 3.64

See More

52-Week High 17.17
Fibonacci 61.8% 11.51
Fibonacci 50% 9.76
Fibonacci 38.2% 8.01
Last Price 3.73
52-Week Low 2.35

See More

Business Summary

Helius Medical Technologies Inc are a medical technology company. It is focused on the development of products for the treatment of neurological symptoms caused by disease or trauma. The company has developed its first, known as the portable neuromodulation stimulator or PoNS, device, is designed to...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar